Market Overview:

The Global Blood Processing Devices Market Size Was Estimated At USD 41.82 Billion In 2022 At A CAGR 10.55% To Reach USD 93.35 Billion By 2030.

Blood processing machines are also used in hospitals for blood transfusions and at diagnostic centers to find out if someone has cancer or heart disease. In the process of processing blood, refrigerators, cell processors, centrifuges, blood storage bags, blood collection tubes, and other reagents are used. Blood transfusions and processing are needed for many surgeries, stem cell therapies, and organ transplants. This is expected to drive the global market for blood processing devices and supplies. Also, the growth of the market can be explained by the fact that blood screening is finding more diseases like cancer, diabetes, and heart diseases.

The market for blood processing equipment and supplies is a field that is always changing and has seen many technological advances. As more surgeries and other procedures that require blood transfusions are done, there is a growing market for safe blood supplies. Several blood processing machines and blood processing supplies are used to keep people from getting sick when they get blood transfusions or donate blood.

Devices that process blood are also used in diagnostic centers to find out if someone has diabetes, cancer, or a heart disease, and in hospitals to give blood transfusions. Various blood processing tools and supplies, such as refrigerators, cell processors, centrifuges, blood storage bags, blood collection tubes, and other reagents, are used to process blood. Surgical procedures, stem cell therapy, and organ transplants all need blood transfusions and processing of blood. This is expected to drive the global market for blood processing devices and supplies.

COVID-19 Impact:

The COVID-19 pandemic has had a big effect on the devices and supplies used to process blood. Here are a few ways that the pandemic has changed this market:

Blood donations: Because of the COVID-19 pandemic and other things, there has been a big drop in the number of people who give blood. This has led to a shortage of blood and blood products, which has changed the demand for devices and supplies used to process blood.

Demand for blood transfusions: The COVID-19 pandemic has increased the need for blood transfusions in some situations, like when treating COVID-19 patients who are very sick. This has made more people want blood processing tools and supplies.

Supply chain problems: The COVID-19 pandemic has caused problems in supply chains around the world, including those for blood processing devices and supplies. This has caused some products to run out, shipments to be delayed, and prices to go up.

Changes to the rules: The COVID-19 pandemic has caused changes to the rules for blood processing devices and supplies. For example, regulatory bodies like the FDA have put out advice and temporary rules to make it easier to collect blood and blood products and process them during the pandemic.

Market Trends:

• The Rising Demand for Blood and Its Various Products

One of the main things driving market growth is the increasing number of surgeries, which is driving up the demand for blood and its products, like white blood cells (WBCs), red blood cells (RBCs), and plasma. Healthcare facilities use a lot of blood processing devices and consumables to collect, process, transport, and store blood products. This is because they ensure safety, improve clinical efficiency, increase patient safety, keep blood efficacy, and stop contaminations. In addition to this, the growing number of blood disorders like sickle cell anemia and thalassemia is also causing growth. Also, the implementation of supportive policies by government and non-government organizations to encourage blood donation, educate the public, and fund programs to collect and process blood is helping the market grow. Also, the recent development of a closed blood sampling system, which uses a needleless connection between the blood collection set and the blood bag to reduce the risk of infection, contamination, and needlestick injuries, is helping the market grow. Aside from this, the introduction of automated blood processing systems that can do multiple steps at once, improving overall efficiency, reducing manual labor, lowering operational costs, and saving time is helping the market grow. The market is also growing because there is more demand for point-of-care testing, which lets doctors do blood tests and get samples quickly from patients at their homes. The market is expected to grow because of other factors, such as the fast growth of the healthcare industry, the rising number of trauma cases caused by things like accidents, violence, and natural disasters, and the rising investments in the development of advanced devices.

Driving Factors:

• Rise in Prevalence of Blood Transfusion Diseases

Blood screening tests are needed for blood transfusion disorders, infectious diseases, and sickle cell disease. Because of this, the global market for blood processing devices and consumables is expected to grow over the next few years. Sickle cell disease is a genetically inherited condition in which red blood cells are unable to transport enough oxygen throughout the body. Because of this, these patients would need regular blood transfusions at set times, which would boost the global market for blood processing devices and supplies.

• Increased Number of Surgeries and Hospitals

The growth of the global blood collection devices market is likely to be driven by the growing number of hospitals, outpatient surgery centers, and diagnostic laboratories around the world. Since there are more hospitals and other health care facilities, more blood collection devices are needed. This market is also expected to grow because more people are learning about how safe and easy it is to use modern blood collection devices. This market is also growing because the government is doing more and more to encourage the use of advanced medical technologies.

• Rising Prevalence of Inherited Blood Disorders

If there is something wrong with the blood, it could hurt the body as a whole. Platelet disorders, bleeding problems, and excessive clotting, which can affect how the blood clots, anemia, blood cancers like myeloma and leukemia, and eosinophilic disorders, which are problems with a certain type of white blood cells, are some of the different types of blood disorders. According to the World Health Organization, most hemoglobin disorders were found in 60% of the 229 countries they looked at, and they affected 75% of births. This makes policymakers want to find the best ways to treat the problem. One in every 5,000 male babies born in the United States has a condition called hemophilia A. About 400 babies are born with hemophilia every year.

Restraints/Challenges:

• High Cost of Automated Blood Collection Devices

A big problem for the global blood collection devices market is that automated blood collection devices are very expensive. The cost of automated blood collection devices can be a big problem for hospitals and other medical facilities. Also, they can be very expensive to keep up because they need to be maintained and calibrated regularly. This makes them more expensive to own, which makes them out of reach for many healthcare facilities. This is likely to slow the growth of the market for blood collection devices around the world.

• Increasing Complexities of Storage and Shipping

The fact that blood collection devices are getting harder to store and ship is one of the biggest problems the global market is facing. Also, keeping these devices sterile is a big problem. Temperature-controlled storage and shipping systems are also getting more expensive to buy and keep up, which is a big problem for the companies that make them. The market also has to deal with the fact that these devices have to meet strict regulations before they can be sold.

• Lack of Skilled Professionals

Blood processing and transfusions need people with a lot of training, but many countries don't have enough trained people. This could make it harder for devices and supplies for processing blood to be used.

• Stringent Regulatory Requirements

The market for blood processing devices and supplies is highly regulated, and following the rules can take a lot of time and cost a lot of money. This could make it harder for new people to join the market.

Opportunities:

• Innovative Techniques and Research

The global market for blood processing devices and supplies is expected to grow thanks to new innovations and more research in the field of life sciences that will help make blood processing more efficient and effective. For example, the June 2021 report from Kings College London says that neurodegenerative diseases like Down syndrome can be diagnosed by measuring the amount of a protein called neurofilament light chain in the blood. The global market for blood processing devices and supplies is expected to be driven by research and development in blood screening, which requires processing blood.

• Feasible and Effective Modality

Blood banks and medical centers use a lot of blood treatment devices and supplies to store, process, and take care of donated blood. These devices help keep blood parts in their original form so that they can be stored and given to someone else. Changing blood parts can be useless. For example, Hepatitis and Acquired Immunodeficiency Syndrome (AIDS) are two major infectious diseases that are hard to prevent and treat. This makes it hard for health care providers to deal with them. So, devices and supplies for processing blood are used to stop these infections.

• Increasing Demand for Apheresis

Because more people are using apheresis to separate blood components, the global market for blood collection devices is expected to grow at a fast rate. Apheresis is a medical procedure where a person's blood is put through a machine that separates out one part. This part is then taken away, and the other parts are put back into the body. This method is being used more and more to get plasma, red blood cells, platelets, and other parts of the blood for medical purposes. Also, the growing number of chronic diseases like cancer and heart disease is helping the market grow because it makes it easier to get the right blood components to treat these diseases. The growth of the market is also helped by the fact that more people are learning about the benefits of blood component separations.

Strategic Development:

• In 2021 - Greiner Bio-One introduced the MiniCollect PIXIE Heel Incision Safety Lancet to add a new safety lancet made especially for heel incisions. The company now has three types of lancets to meet the needs of different people.
• In 2021 - Quest Diagnostics, Inc. will buy Nationwide Laboratory Services in Boca Raton. With the purchase, Quest will give more people in South Florida access to diagnostic innovations and insights that will help them live healthier lives.
• In July 2020 - Magnolia Medical will release Steripath Gen2 with an integrated syringe. This product is for people who have trouble getting an IV or who are hard to stick.
• In September 2021 - Terumo BCT said that it was putting out new software for its Finia Fill and Finish System. With the launch, the company grew its range of automated solutions to help this industry, which is changing quickly. Along with this, the company would come up with new ways to make cell and gene therapies safer to make, easier to scale up, and more marketable to meet the needs of a growing number of patients around the world.
• In July of 2021 - Becton, Dickinson, and Company joined forces with BioMedomics, a clinical diagnostics company based in North Carolina that is privately owned. Together, the two companies released a new point-of-care test that can confirm exposure to COVID-19 by finding antibodies in the blood within 15 minutes. The test was made by BioMedomics and would be available through BD. It would only be sold to health care providers in the United States by Henry Schein, Inc.

Key Vendors:

Top market players are

• Abbott (US)

Abbott is a global leader in health care that helps people live their lives to the fullest at all stages. The portfolio of life-changing technologies includes leading businesses and products in diagnostics, medical devices, nutrition, and brand-name generic medicines.

• Biomerieux (France)

As a division of Institut Merieux SA, bioMerieux SA (bioMerieux) creates, makes, and sells in vitro diagnostic solutions for hospital and private labs. The company sells systems, reagents, and software for identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products, as well as for diagnosing infectious diseases, cardiovascular diseases, and cancers.

• BD(US)

BD (Becton, Dickinson and Company) is a medical technology company that develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products. It has three different kinds of business: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment offers systems for delivering and managing medications as well as solutions for delivering and managing medications.

• Bio-Rad Laboratories. Inc (US)

Bio-Rad Laboratories, Inc. (Bio-Rad) designs, makes, and sells a wide range of products and systems for life science research, healthcare, analytical chemistry, and other fields. The company's main products are reagents, equipment, laboratory instruments, test systems, information systems, test kits, and specialized quality controls.

• Danaher (US)

Danaher is a global leader in science and technology. They help their customers solve difficult problems and improve the quality of life for people all over the world. The global network of more than 25 operating companies that drive innovation in some of the most exciting industries of today.

• Grifols S.A (India)

Grifols SA (Grifols) is a company that makes pharmaceuticals and chemicals to improve the health and well-being of patients all over the world. It focuses on research, development, manufacturing, and marketing of plasma-derived therapies, hospital pharmacy products, and diagnostic technology for clinical use.

• Thermogenesis Holdings. Inc (US)

ThermoGenesis Holdings Inc., which used to be called Cesca Therapeutics Inc., studies, develops, and sells cell-based therapies for use in regenerative medicine. It uses its own technology platform, PXP, to create cell-based therapies for the vascular and orthopedic markets.

• Terumo Corporation (Japan)

Terumo Corp. (Terumo) makes and sells medical care products, such as hospital and medical equipment and supplies. Pharmaceuticals, blood bags, disposable medical devices, dietary supplements, cardiovascular systems, vascular grafts, blood glucose monitoring systems, medical electronics, peritoneal dialysis, and digital thermometers are some of the company's most important product lines.

• F. Hoffmann-La Roche Ltd (Switzerland)

Roche, which is part of F. Hoffmann-La Roche Ltd, is a biotechnology company that makes medicines and tests to treat major diseases. It has medicines for treating cancer, other autoimmune diseases, problems with the central nervous system, eye problems, infectious diseases, and lung diseases. The company also offers in vitro diagnostics, cancer diagnostics based on tissue samples, and solutions for managing diabetes.

• Haemonetics Corporation (US)

Haemonetics is a global healthcare company whose goal is to help customers improve patient care and lower the cost of healthcare by giving them a suite of innovative medical products and solutions. The technology serves important medical markets like the collection of blood and plasma components, the operating room, and hospital transfusion services.

Segmentation Analysis:

The market is segmented on the basis of product, application, end-user and region.

By Product Outlook:

Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors, and Lancets are the different types of products in the market. In 2020, needles and syringes made up a big part of the blood collection market in terms of revenue. This is because of the high affordability, high adoption, and repeat purchase of syringes & needles. The market for blood collection devices would grow even more as the need for needles and syringes grew. In 2020, blood bags were a promising part of the market for blood collection.

Blood bags are used to carry and store blood from patients that needs to be transferred or analyzed. The number of accidents and surgeries is going up, which is why this market is growing. According to statistics from the American Red Cross for 2018, the U.S. needs about 36,000 units of RBCs every day.

• Blood Collection Tubes
• Needles & Syringes
• Blood Bags
• Blood Collection Systems/Monitors
• Lancets

By Application Outlook:

Blood Transfusion: Devices that are used to process and give whole blood or parts of blood (like red blood cells, platelets, or plasma) to people who need them because of illness, surgery, or an accident.

Therapeutic Applications: Blood processing devices are used in procedures like apheresis, in which specific blood components are removed or collected for therapeutic purposes, like plateletpheresis or plasmapheresis.

Diagnostic and Research: Blood processing devices are used in clinical laboratories for diagnostic testing, research, and the development of new therapies or medical products.

• Blood Transfusion
• Therapeutic Applications
• Diagnostic and Research

By End-User:

Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, & Nursing Homes; Diagnostic & Pathology Laboratories, Blood Banks and Others. The diagnostic and pathology laboratories segment of the blood collection devices market brought in a lot of money in 2020. The fact that these labs can be found in different places is the main reason why this segment is growing. Additionally, the increasing number of tests due to the rising number of diseases and the growing presence of online websites are some other factors supporting market growth.

• Hospitals, Ambulatory Surgical Centers, & Nursing Homes
• Diagnostic & Pathology Laboratories
• Blood Banks
• Others

Regional Insights:

North America is the biggest market for blood processing devices and supplies. This is mostly because of the high demand for blood and blood products, the well-established healthcare infrastructure, and the friendly regulatory environment. Most of the market in this area comes from the United States and Canada.

Europe is another big market for blood processing equipment and supplies. This is because there is a growing need for blood products and a well-developed healthcare system in Europe. Most of the market in this area comes from the United Kingdom, Germany, and France.

Asia Pacific: The Asia Pacific region is expected to witness significant growth in the blood processing devices and consumables market due to the increasing demand for blood products, expanding healthcare infrastructure, and rising healthcare spending. Most of the market in this region comes from China, Japan, and India.

Latin America: Latin America is a growing market for blood processing equipment and supplies because there is more demand for blood products, the healthcare system is getting better, and people are spending more money on healthcare. Most of the market in this area comes from Brazil and Mexico.

Middle East and Africa: The blood processing devices and consumables market is expected to grow slowly in the Middle East and Africa because there is more demand for blood products and healthcare infrastructure is getting better. Most of the market in this area comes from South Africa, Saudi Arabia, and the United Arab Emirates.

Overall, North America and Europe are the biggest markets for blood processing devices and supplies, but Asia Pacific is expected to grow the fastest in the coming years.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Scope of Report:

Conclusion:

• The report also gives a thorough look at how competition works in the global market for blood processing devices and supplies.
• The report goes over competitive analysis, including market structure, market share by key players, player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant.
• Also, there are detailed profiles of all the big companies.
• Competitive intelligence about the top makers and sellers of blood processing devices and supplies helps make sense of the competitive landscape in different places.
• Analysis of current research and clinical developments within the market is provided with key market dynamic factors to predict the behaviour of the market.